Factor | Dosage regimen | Dietary advice | Adverse effects | Re-engagement | Malaria prevention | |||||
---|---|---|---|---|---|---|---|---|---|---|
OR (95% CI) | p | OR (95% CI) | p | OR (95% CI) | p | OR (95% CI) | p | OR (95% CI) | p | |
Interviewee | ||||||||||
Patient | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |||||
Caregiver | 1.1 (0.4, 3.0) | 0.78 | 0.3 (0.1, 0.9) | 0.03 | 0.1 (<0.1, 1.0) | 0.05 | 0.9 (0.4, 1.9) | 0.82 | 2.4 (0.9, 6.4) | 0.07 |
Patient sex | ||||||||||
Male | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |||||
Female | 0.7 (0.4, 1.2) | 0.24 | 1.5 (0.6, 4.1) | 0.39 | 0.1 (<0.1, 0.9) | 0.04 | 0.8 (0.5, 1.2) | 0.26 | 0.9 (0.5, 1.7) | 0.83 |
Patient age | ||||||||||
< 5 yrs | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |||||
5 yrs + | 1.1 (0.6, 2.0) | 0.86 | 1.0 (0.4, 2.5) | 0.99 | 2.6 (0.3, 19.5) | 0.33 | 1.0 (0.5, 1.8) | 0.97 | 1.8 (0.8, 4.3) | 0.17 |
Consult time | ||||||||||
<17 mins | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |||||
17 mins + | 1.2 (0.6, 2.1) | 0.63 | 0.7 (0.2, 2.1) | 0.51 | 0.1 (<0.1, 0.8) | 0.04 | 1.5 (0.8, 2.8) | 0.19 | 0.6 (0.3, 1.4) | 0.26 |